Menu

Close

Here's the text.

About Ebola hemorrhagic fever and Middle East Respiratory Syndrome (MERS)

Last Updated March 28, 2024

What is Ebola hemorrhagic fever?

Characteristics of Ebola hemorrhagic fever
Causes   Ebolavirus
Path of infectionWhen the patient touches the body fluids (blood, secretions, vomit / excrement) of a patient whose symptoms are manifested without sufficient protection, the virus invades through wounds and mucous membranes and becomes infected.
In endemic areas, wildlife can also be transmitted from wild animals.
Generally, it is not transmitted from asymptomatic patients and there is no airborne infection.
Occurrence areaGuinea, Sierra Leone, Liberia, Uganda, Sudan, Gabon, Cote d'Ivoire, Democratic Republic of Congo, Republic of the Congo, Republic of the Congo
SymptomsAfter an incubation period of 2 to 21 days (usually 7 to 10 days), symptoms such as sudden fever, headache, malaise, muscle pain, and sore throat appear.

Prevention and
Treatment of treatment

Currently, there are no vaccines or specific treatment. Symptomatic treatment is given according to the patient's symptoms.
  • Since March 2014, major outbreaks have occurred in Guinea, Liberia, Sierra Leone, Mali and Nigeria in western Africa.

What is Middle East Respiratory Syndrome (MERS)?

Characteristics of Middle East Respiratory Syndrome (MERS)
Causes   MERS coronavirus (confirmed for the first time in 2012)
Path of infectionHow humans become infected is still unclear exactly.
Dromedary camels are said to be a type of animal infected with the MERS virus, but many patients have no history of contact with animals. Infections have also been reported between close contacts, such as between families, between patients in medical institutions with inadequate infection control measures, and between patients and healthcare professionals.
Occurrence areaUnited Arab Emirates, Yemen, Oman, Qatar, Kuwait, Saudi Arabia, Jordan
SymptomsAfter an incubation period of about 2 to 14 days, most patients will develop pneumonia due to fever and acute severe respiratory symptoms. Some patients may be mildly ill or atypical findings.

Prevention and
Treatment of treatment

Currently, there are no vaccines or specific treatment. Symptomatic treatment is given according to the patient's symptoms.

To the citizens

 If it is unavoidable to travel to the affected area, use the "Country / Region Information" (external site) of the Ministry of Health, Labour and Welfare Quarantine Station FORTH and "Overseas Safety Information" (external site) of the Ministry of Foreign Affairs' "Overseas Safety Information" (external site). Check the situation, consider whether or not to travel, and make sure to take basic hygiene measures (hand washing, avoid contact with patients and animals, avoid contact with patients and animals, etc.)
 If you experience symptoms after traveling to the affected area or contact with an infected person, do not consult a medical institution directly. Please call the Health and Welfare Center Health and Welfare Division Health Promotion Section in each ward.                                         
※Please contact the Yokohama City Public Health Center Infectious Disease Food Poisoning Emergency Call Dial in case of emergency in case of any of the above during weekday business hours. Please refrain from contacting us if there is no urgency for emergency use during night holidays.

To Medical Institutions

Related Sites

Ebola hemorrhagic fever


 

Middle East Respiratory Syndrome (MERS)

In order to open PDF files, you may need a separate PDF reader.
If you do not have it, you can download it free of charge from Adobe.
Get Adobe Acrobat Reader DCTo download Adobe Acrobat Reader DC

For inquiries to this page

Health and Safety Division, Medical Care Bureau Health and Safety Department

Phone: 045-671-2463

Phone: 045-671-2463

Fax: 045-664-7296

Email address: ir-kenkoanzen@city.yokohama.jp

Return to the previous page

Page ID: 592-378-795

Menu

  • LINE
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • SmartNews